Showing results (41-50 of 174) with videos related to

Sort By:
Pageof 18
British Journal of Cancer|November 19, 2009
Costs of managing adverse events in the treatment of first-line metastatic renal cell carcinoma: bevacizumab in combination with interferon-alpha2a compared with sunitinibG Mickisch, M Gore, B Escudier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2010
Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinomaS Antoun, V E Baracos, L Birdsell, et al.
Infection Control and Hospital Epidemiology|January 1, 1990
Effectiveness of simple measures to control an outbreak of nosocomial methicillin-resistant Staphylococcus aureus infections in an intensive care unitM Guiguet, C Rekacewicz, B Leclercq, et al.
The Journal of Urology|February 1, 1994
Recombinant interferon-alpha efficacy in relapsed adult nephroblastoma: a case reportJ Kattan, J P Droz, S Culine, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 1, 1995
Early tracheotomy in neutropenic, mechanically ventilated patients: rationale and results of a pilot studyF Blot, M Guiguet, S Antoun, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 15, 2010
How to select targeted therapy in renal cell cancerB Escudier, L Albiges, A Blesius, et al.
Biotherapy (Dordrecht, Netherlands)|January 1, 1992
Studies on NK cell purification by negative selection in human peripheral bloodF Farace, A M Le Ridant, B Escudier, et al.
Intensive Care Medicine|January 1, 1990
Acute myocardiotoxicity during 5-fluorouracil therapyB Misset, B Escudier, B Leclercq, et al.
European Journal of Cancer (Oxford, England : 1990)|June 1, 1997
Prognostic factors for neutropenic patients in an intensive care unit: respective roles of underlying malignancies and acute organ failuresF Blot, M Guiguet, G Nitenberg, et al.
The Cancer Journal From Scientific American|February 24, 2000
Long-term follow-up of patients with metastatic renal cell carcinoma treated with intravenous recombinant interleukin-2 in EuropeS Negrier, J Maral, M Drevon, et al.
Pageof 18